Difference between revisions of "Peripartum cardiomyopathy"

(Text replacement - "*Tintinalli" to "")
(Text replacement - "==Treatment==" to "==Management==")
Line 28: Line 28:
 
#TTE
 
#TTE
  
==Treatment==
+
==Management==
 
*Treat like usual heart failure (except avoid nitroprusside and ACEI)
 
*Treat like usual heart failure (except avoid nitroprusside and ACEI)
  

Revision as of 21:05, 8 July 2016

Background

  • Disease earlier than last month of pregnancy is likely the same process of HF

Diagnosis

  • Presentation similar to typical CHF
  • 4 criteria needed to meet definition for PPCM:
    • Development of heart failure in last month of pregnancy or w/in 5mo of delivery
    • Absence of an identifiable cause for the heart failure
    • Absence of recognizable heart disease prior to the last month of pregnancy
    • LV systolic dysfunction, such as LVEF < 45%

Differential Diagnosis

  • Respiratory tract infection
  • PE
  • MI
  • Postpartum fluid overload

Cardiomyopathy

3rd Trimester/Postpartum Emergencies

Work-Up

  1. ECG
  2. CXR
  3. CBC
  4. Chemistry
  5. TSH
  6. TTE

Management

  • Treat like usual heart failure (except avoid nitroprusside and ACEI)

See Also

References


  • Elkayam U et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005 Apr 26; 111(16): 2050-5.